This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v2-0227"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p>Manufacturers of Vaccines (code=MVX)</p> <table class="grid"> <tr> <td> <b>Code</b> </td> <td> <b>Description</b> </td> <td> <b>Nederlands (Dutch)</b> </td> <td> <b>Comment</b> </td> <td> <b>Version</b> </td> </tr> <tr> <td>ab <a name="ab"> </a> </td> <td>Abbott Laboratories</td> <td>Abbott Laboratories</td> <td>(includes Ross Products Division)</td> <td>added v2.3</td> </tr> <tr> <td>ad <a name="ad"> </a> </td> <td>Adams Laboratories, Inc.</td> <td>Adams Laboratories, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>alp <a name="alp"> </a> </td> <td>Alpha Therapeutic Corporation</td> <td>Alpha Therapeutic Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>ar <a name="ar"> </a> </td> <td>Armour</td> <td>Armour</td> <td>[Inactive--use AVB]</td> <td>added v2.3</td> </tr> <tr> <td>avb <a name="avb"> </a> </td> <td>Aventis Behring L.L.C.</td> <td>Aventis Behring L.L.C.</td> <td>(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006</td> <td>added v2.5</td> </tr> <tr> <td>avi <a name="avi"> </a> </td> <td>Aviron</td> <td>Aviron</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>ba <a name="ba"> </a> </td> <td>Baxter Healthcare Corporation</td> <td>Baxter Healthcare Corporation</td> <td>[Inactive--use BAH]</td> <td>added v2.3</td> </tr> <tr> <td>bah <a name="bah"> </a> </td> <td>Baxter Healthcare Corporation</td> <td>Baxter Healthcare Corporation</td> <td>(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)</td> <td>added v2.5</td> </tr> <tr> <td>bay <a name="bay"> </a> </td> <td>Bayer Corporation</td> <td>Bayer Corporation</td> <td>(includes Miles, Inc. and Cutter Laboratories)</td> <td>added v2.3</td> </tr> <tr> <td>bp <a name="bp"> </a> </td> <td>Berna Products</td> <td>Berna Products</td> <td>[Inactive--use BPC]</td> <td>added v2.3</td> </tr> <tr> <td>bpc <a name="bpc"> </a> </td> <td>Berna Products Corporation</td> <td>Berna Products Corporation</td> <td>(includes Swiss Serum and Vaccine Institute Berne)</td> <td>added v2.3.1</td> </tr> <tr> <td>cen <a name="cen"> </a> </td> <td>Centeon L.L.C.</td> <td>Centeon L.L.C.</td> <td>[Inactive--use AVB]</td> <td>added v2.3.1</td> </tr> <tr> <td>chi <a name="chi"> </a> </td> <td>Chiron Corporation</td> <td>Chiron Corporation</td> <td>[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006</td> <td>added v2.3.1</td> </tr> <tr> <td>cmp <a name="cmp"> </a> </td> <td>Celltech Medeva Pharmaceuticals</td> <td>Celltech Medeva Pharmaceuticals</td> <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.5</td> </tr> <tr> <td>cnj <a name="cnj"> </a> </td> <td>Cangene Corporation</td> <td>Cangene Corporation</td> <td>CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> <tr> <td>con <a name="con"> </a> </td> <td>Connaught</td> <td>Connaught</td> <td>[Inactive--use PMC]</td> <td>added v2.3</td> </tr> <tr> <td>dvc <a name="dvc"> </a> </td> <td>DynPort Vaccine Company, LLC</td> <td>DynPort Vaccine Company, LLC</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>evn <a name="evn"> </a> </td> <td>Evans Medical Limited</td> <td>Evans Medical Limited</td> <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.3</td> </tr> <tr> <td>geo <a name="geo"> </a> </td> <td>GeoVax Labs, Inc.</td> <td>GeoVax Labs, Inc.</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>gre <a name="gre"> </a> </td> <td>Greer Laboratories, Inc.</td> <td>Greer Laboratories, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>iag <a name="iag"> </a> </td> <td>Immuno International AG</td> <td>Immuno International AG</td> <td>[Inactive--use BAH]</td> <td>added v2.3.1</td> </tr> <tr> <td>im <a name="im"> </a> </td> <td>Merieux</td> <td>Merieux</td> <td>[Inactive--use PMC]</td> <td>added v2.3</td> </tr> <tr> <td>ius <a name="ius"> </a> </td> <td>Immuno-U.S., Inc.</td> <td>Immuno-U.S., Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>jpn <a name="jpn"> </a> </td> <td>The Research Foundation for Microbial Diseases of Osaka University</td> <td>The Research Foundation for Microbial Diseases of Osaka University</td> <td>(BIKEN)</td> <td>added v2.3</td> </tr> <tr> <td>kgc <a name="kgc"> </a> </td> <td>Korea Green Cross Corporation</td> <td>Korea Green Cross Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>led <a name="led"> </a> </td> <td>Lederle</td> <td>Lederle</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>ma <a name="ma"> </a> </td> <td>Massachusetts Public Health Biologic Laboratories</td> <td>Massachusetts Public Health Biologic Laboratories</td> <td>[Inactive--use MBL]</td> <td>added v2.3</td> </tr> <tr> <td>mbl <a name="mbl"> </a> </td> <td>Massachusetts Biologic Laboratories</td> <td>Massachusetts Biologic Laboratories</td> <td>(formerly Massachusetts Public Health Biologic Laboratories)</td> <td>added v2.5</td> </tr> <tr> <td>med <a name="med"> </a> </td> <td>MedImmune, Inc.</td> <td>MedImmune, Inc.</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>mil <a name="mil"> </a> </td> <td>Miles</td> <td>Miles</td> <td>[Inactive--use BAY]</td> <td>added v2.3</td> </tr> <tr> <td>mip <a name="mip"> </a> </td> <td>Bioport Corporation</td> <td>Bioport Corporation</td> <td>(formerly Michigan Biologic Products Institute)</td> <td>added v2.3</td> </tr> <tr> <td>msd <a name="msd"> </a> </td> <td>Merck & Co., Inc.</td> <td>Merck & Co., Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>nab <a name="nab"> </a> </td> <td>NABI</td> <td>NABI</td> <td>(formerly North American Biologicals, Inc.)</td> <td>added v2.3</td> </tr> <tr> <td>nav <a name="nav"> </a> </td> <td>North American Vaccine, Inc.</td> <td>North American Vaccine, Inc.</td> <td>[Inactive--use BAH]</td> <td>added v2.3.1</td> </tr> <tr> <td>nov <a name="nov"> </a> </td> <td>Novartis Pharmaceutical Corporation</td> <td>Novartis Pharmaceutical Corporation</td> <td>(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)</td> <td>added v2.3.1</td> </tr> <tr> <td>nvx <a name="nvx"> </a> </td> <td>Novavax, Inc.</td> <td>Novavax, Inc.</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>nyb <a name="nyb"> </a> </td> <td>New York Blood Center</td> <td>New York Blood Center</td> <td/> <td>added v2.3</td> </tr> <tr> <td>ort <a name="ort"> </a> </td> <td>Ortho-Clinical Diagnostics</td> <td>Ortho-Clinical Diagnostics</td> <td>(formerly Ortho Diagnostic Systems, Inc.)</td> <td>added v2.3.1</td> </tr> <tr> <td>otc <a name="otc"> </a> </td> <td>Organon Teknika Corporation</td> <td>Organon Teknika Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>oth <a name="oth"> </a> </td> <td>Other manufacturer</td> <td>Andere fabrikant</td> <td/> <td>added v2.3</td> </tr> <tr> <td>pd <a name="pd"> </a> </td> <td>Parkedale Pharmaceuticals</td> <td>Parkedale Pharmaceuticals</td> <td>(formerly Parke-Davis)</td> <td>added v2.3</td> </tr> <tr> <td>pmc <a name="pmc"> </a> </td> <td>sanofi pasteur</td> <td>sanofi pasteur</td> <td>(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.3.1</td> </tr> <tr> <td>prx <a name="prx"> </a> </td> <td>Praxis Biologics</td> <td>Praxis Biologics</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>pwj <a name="pwj"> </a> </td> <td>PowderJect Pharmaceuticals</td> <td>PowderJect Pharmaceuticals</td> <td>(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.5</td> </tr> <tr> <td>scl <a name="scl"> </a> </td> <td>Sclavo, Inc.</td> <td>Sclavo, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>si <a name="si"> </a> </td> <td>Swiss Serum and Vaccine Inst.</td> <td>Swiss Serum and Vaccine Inst.</td> <td>[Inactive--use BPC]</td> <td>added v2.3</td> </tr> <tr> <td>skb <a name="skb"> </a> </td> <td>GlaxoSmithKline</td> <td>GlaxoSmithKline</td> <td>(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)</td> <td>added v2.3</td> </tr> <tr> <td>sol <a name="sol"> </a> </td> <td>Solvay Pharmaceuticals</td> <td>Solvay, Pharmaceuticals</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>tal <a name="tal"> </a> </td> <td>Talecris Biotherapeutics</td> <td>Talecris Biotherapeutics</td> <td>(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> <tr> <td>unk <a name="unk"> </a> </td> <td>Unknown manufacturer</td> <td>Unknown manufacturer</td> <td/> <td>added v2.3</td> </tr> <tr> <td>usa <a name="usa"> </a> </td> <td>United States Army Medical Research and Material Command</td> <td>United States Army Medical Research and Material Command</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>vxg <a name="vxg"> </a> </td> <td>VaxGen</td> <td>VaxGen</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>wa <a name="wa"> </a> </td> <td>Wyeth-Ayerst</td> <td>Wyeth-Ayerst</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>wal <a name="wal"> </a> </td> <td>Wyeth-Ayerst</td> <td>Wyeth-Ayerst</td> <td>(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)</td> <td>added v2.3.1</td> </tr> <tr> <td>zlb <a name="zlb"> </a> </td> <td>ZLB Behring</td> <td>ZLB Behring</td> <td>(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ValueSet/v2-0227"/> <version value="2.8.2"/> <name value="v2 Manufacturers of Vaccines (code=MVX)"/> <status value="active"/> <experimental value="true"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="other"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))"/> <compose> <include> <system value="http://hl7.org/fhir/v2/0227"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.